Sector: Health Care.Industry: Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-13 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.240 | ||||||
| REV | 10.916K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INMB | INmune Bio | -7.48% | 162.6M |
INmune Bio Company Questions & Answers
Q
How do I buy INmune Bio (INMB) stock?
A
You can purchase shares of INmune Bio (NASDAQ: INMB) through any online brokerage.
Q
Who are INmune Bio's (INMB) main competitors?
A
Other companies in INmune Bio’s space includes: Heat Biologics (NASDAQ:HTBX), Voyager Therapeutics (NASDAQ:VYGR) and DiaMedica Therapeutics (NASDAQ:DMAC).
Q
What is the target price for INmune Bio?
A
The latest price target for INmune Bio (NASDAQ: INMB) was reported by HC Wainwright & Co. on 2020-11-09. The analyst firm set a price target for 15.00 expecting INMB to rise to within 12 months (a possible 37.74% upside). 4 analyst firms have reported ratings in the last year.
Q
How much is INmune Bio (INMB) stock ?
A
The stock price for INmune Bio (NASDAQ: INMB) is $10.89 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next INmune Bio (INMB) dividend?
A
There are no upcoming dividends for INmune Bio.
Q
When is INmune Bio (NASDAQ:INMB) reporting earnings?
A
INmune Bio’s Q1 earnings are confirmed from now on May 13, 2021.
Q
When is the upcoming split for INMB?
A
There is no upcoming split for INmune Bio.